• DAPIPRAZOLE CHEMBL1201216 FDA Approved

    Alternate Names:

    Dapiprazole
    REMYDRIAL
    S-TRIAZOLO(4,3-A)PYRIDINE, 5,6,7,8-TETRAHYDRO-3-(2-(4-(O-TOLYL)-1-PIPERAZINYL)ETHYL)-,HYDROCHLORIDE
    AC1MHVUH
    3-[2-[4-(2-METHYLPHENYL)PIPERAZIN-1-YL]ETHYL]-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRIDINE
    DAP000298
    DAPIPRAZOL
    LS-156734
    CID3033538
    REV-EYES
    3-{2-[4-(2-METHYLPHENYL)PIPERAZIN-1-YL]ETHYL}-5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE
    DAPIPRAZOL [GERMAN]
    1,2,4-TRIAZOLO(4,3-A)PYRIDINE, 5,6,7,8-TETRAHYDRO-3-(2-(4-(2-METHYLPHENYL)-1-PIPERAZINYL)ETHYL)-
    C19H27N5
    DAPIPRAZOLE [INN]
    DAPIPRAZOLUM
    L000681
    DAPIRAZOLUM
    D07775
    72822-12-9
    3033538
    3-(2-(4-(2-METHYLPHENYL)-1-PIPERAZINYL)ETHYL)-5,6,7,8,-TETRAHYDRO-1,2,4-TRIAZOLO(4,3-A)PYRIDINE HYDROCHLORIDE
    189873
    DAPIRAZOL
    DB00298
    DAPIRAZOLUM [INN-LATIN]
    REVERSIL
    UNII-DS9UJN1I0X
    CHEBI:51066
    5,6,7,8-TETRAHYDRO-3-(2-(4-(O-TOLYL)-1-PIPERAZINYL)ETHYL)-S-TRIAZOLO(4,3-A)PYRIDINE
    DAPIPRAZOLE (INN)
    DAPIRAZOL [INN-SPANISH]
    GLAMIDOLO
    3B1-007681
    3B2-1233
    FT-0603131
    HE383766
    DR001484
    AK163348
    AN-6809
    AKOS024463973
    ZINC1246
    GTPL7155
    SCHEMBL152543
    5RNZ8GJO7K
    3-[2-[4-(O-TOLYL)PIPERAZIN-1-YL]ETHYL]-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRIDINE
    REV-EYESREG
    3-(2-(4-(O-TOLYL)PIPERAZIN-1-YL)ETHYL)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRIDINE
    1-(2-METHYLPHENYL)-4-(2-{5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL}ETHYL)PIPERAZINE
    UNII-5RNZ8GJO7K
    178103730
    7155

    Drug Info:

    Year of Approval 1990
    Drug Class ophthalmologicals
    FDA Approval 1990
    Drug Class small molecule
    Drug Indications ophthalmological agent
    Drug Categories tranquilizing agents
    Drug Categories therapeutic uses
    Drug Categories sensory organs
    Drug Categories psychotropic drugs
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories ophthalmologicals
    Drug Categories ophthalmics
    Drug Categories neurotransmitter agents
    Drug Categories molecular mechanisms of pharmacological action
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories chemical actions and uses
    Drug Categories central nervous system depressants
    Drug Categories central nervous system agents
    Drug Categories azoles
    Drug Categories antipsychotic agents
    Drug Categories antiglaucoma preparations and miotics
    Drug Categories alpha1 antagonists
    Drug Categories adrenergic antagonists
    Drug Categories adrenergic alpha-antagonists
    Drug Categories adrenergic agents
    Drug Groups approved
    Drug Type small molecule
    (2 More Sources)